What therapies are most effective for patients with double-expressor lymphoma in terms of survival outcomes?

Tucidinostat combined with R-CHOP shows promise in improving survival outcomes for patients with double-expressor lymphoma compared to R-CHOP alone, although further dedicated studies are needed to establish definitive therapeutic strategies for this high-risk group.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-06
DOI
https://doi.org/10.5281/zenodo.24015740
Primary Topic
Lymphoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What therapies are most effective for patients with double-expressor lymphoma in terms of survival outcomes?

Tripdatabase
3 links
Zenodo (CERN European Organization for Nuclear Research)
Lymphoma Diagnosis and Treatment
article

What therapies are most effective for patients with double-expressor lymphoma in terms of survival outcomes?

Tripdatabase
article en

Abstract

Tucidinostat combined with R-CHOP shows promise in improving survival outcomes for patients with double-expressor lymphoma compared to R-CHOP alone, although further dedicated studies are needed to establish definitive therapeutic strategies for this high-risk group.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 10%
Lymphoma Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
What therapies are most effective for patients with double-expressor lymphoma in terms of survival outcomes? — Tripdatabase · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS